B. 1. De-dreuille, O. Maszelin, P. Foehrenbach, H. Bonardel, G. Gaillard et al., Principe et technique de la tomographie par ??mission de positons (TEP), EMC - Radiologie, vol.1, issue.1, 2002.
DOI : 10.1016/j.emcrad.2003.12.001

M. Hediger, B. Clemencon, R. Burrier, and E. Bruford, The ABCs of membrane transporters in health and disease (SLC series): introduction. Molecular aspects of medicine, pp.95-107, 2013.

M. Mueckler and B. Thorens, The SLC2 (GLUT) family of membrane transporters. Molecular aspects of medicine, pp.121-138, 2013.

J. Deichen, O. Prante, M. Gack, K. Schmiedehausen, and T. Kuwert, Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. European journal of nuclear medicine and molecular imaging, pp.267-273, 2003.

A. Montel-hagen, S. Kinet, N. Manel, C. Mongellaz, R. Prohaska et al., Erythrocyte Glut1 Triggers Dehydroascorbic Acid Uptake in Mammals Unable to Synthesize Vitamin C, Cell, vol.132, issue.6, pp.1039-1048, 2008.
DOI : 10.1016/j.cell.2008.01.042

L. Szablewski, Expression of glucose transporters in cancers, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1835, issue.2, pp.164-169, 2013.
DOI : 10.1016/j.bbcan.2012.12.004

B. Thorens, R. Haber, S. Weinstein, O. Boyle, E. Morgello et al., GLUT2, glucose sensing and glucose homeostasis, Diabetologia, vol.115, issue.Suppl, pp.221-232, 1993.
DOI : 10.1172/JCI26309

URL : https://link.springer.com/content/pdf/10.1007%2Fs00125-014-3451-1.pdf

I. Simpson, D. Dwyer, D. Malide, K. Moley, A. Travis et al., The facilitative glucose transporter GLUT3: 20 years of distinction, American Journal of Physiology-Endocrinology and Metabolism, vol.295, issue.2, pp.242-253, 2008.
DOI : 10.1016/0006-8993(95)00888-W

H. Murata, P. Hruz, M. Mueckler, R. Hresko, P. Hruz et al., The mechanism of insulin resistance caused by HIV protease inhibitor therapy. The Journal of biological chemistry HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4 Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. The Journal of clinical endocrinology and metabolism, The Journal of clinical investigation. PloS one, vol.87, issue.9910, pp.1072-1081, 1991.

S. Mcbrayer, J. Cheng, S. Singhal, N. Krett, S. Rosen et al., Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy, Blood, vol.119, issue.20, pp.4686-4697, 2012.
DOI : 10.1182/blood-2011-09-377846

V. Douard and R. Ferraris, Regulation of the fructose transporter GLUT5 in health and disease, American Journal of Physiology-Endocrinology and Metabolism, vol.295, issue.2, pp.227-237, 2008.
DOI : 10.1042/bj3110517

URL : https://hal.archives-ouvertes.fr/hal-01606577

G. Mantych, D. James, S. Devaskar, I. Concha, F. Velasquez et al., Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier Human erythrocytes express GLUT5 and transport fructose Antiserum against human glucose transporter 5 is highly specific for microglia among cells of the mononuclear phagocyte system, Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections, pp.157-162, 1993.

Q. Li, A. Manolescu, M. Ritzel, S. Yao, M. Slugoski et al., Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine American journal of physiology Gastrointestinal and liver physiology The glucose transport facilitator GLUT8 is predominantly associated with the acrosomal region of mature spermatozoa. Cell and tissue research, pp.236-242, 2002.

N. Gray, S. Campbell, X. Shu, L. Sawyer, W. Richardson et al., Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking Homozygous SLC2A9 mutations cause severe renal hypouricemia, The Journal of biological chemistry. Journal of the American Society of Nephrology : JASN, vol.279, issue.211, pp.16229-16236, 2004.

L. Mou, L. Jiang, Y. Hu, Y. Shima, K. Nozu et al., A novel homozygous GLUT9 mutation cause recurrent exercise-induced acute renal failure and posterior reversible encephalopathy syndrome Journal of nephrology Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association -European Renal Association, Pediatrics, vol.27, issue.273, pp.1621-1625, 2011.

S. Possenti, M. Colombi, and G. Cancarini, Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity, BMC medical genetics, vol.15, pp.3-30, 2014.

A. Mcvie-wylie, D. Lamson, Y. Chen, L. Hunter, and P. Trayhurn, Molecular Cloning of a Novel Member of the GLUT Family of Transporters, SLC2A10 (GLUT10), Localized on Chromosome 20q13.1: A Candidate Gene for NIDDM Susceptibility, Genomics, vol.72, issue.1, pp.113-117, 2001.
DOI : 10.1006/geno.2000.6457

R. Pyla, N. Poulose, J. Jun, and L. Segar, Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells, American Journal of Physiology-Cell Physiology, vol.266, issue.6, pp.574-589, 2013.
DOI : 10.1152/ajpcell.00670.2008

P. Coucke, A. Willaert, M. Wessels, B. Callewaert, N. Zoppi et al., Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nature genetics Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue, Glucose transporter GLUT12- functional characterization in Xenopus laevis oocytes. Biochemical and biophysical research communications, pp.452-457, 2003.

N. Gude, J. Stevenson, S. Rogers, J. Best, B. Kalionis et al., GLUT12 Expression in Human Placenta in First Trimester and Term, Placenta, vol.24, issue.5, pp.566-570, 2003.
DOI : 10.1053/plac.2002.0925

C. Stuart, M. Howell, Y. Zhang, and D. Yin, Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. The Journal of clinical endocrinology and metabolism, pp.733-738, 2002.

D. Daniel, E. Mok, M. Mead, E. Mutinelli, C. Zambello et al., Evaluation of expression and function of the H+/myo-inositol transporter HMIT, BMC Cell Biology, vol.10, issue.1, pp.54-96, 2009.
DOI : 10.1186/1471-2121-10-54

X. Wu and H. Freeze, GLUT14, a Duplicon of GLUT3, Is Specifically Expressed in Testis as Alternative Splice Forms, Genomics, vol.80, issue.6, pp.553-557, 2002.
DOI : 10.1006/geno.2002.7010

E. Wright, Glucose transport families SLC5 and SLC50. Molecular aspects of medicine, pp.183-196, 2013.
DOI : 10.1016/j.mam.2012.11.002

E. Wright, D. Loo, B. Hirayama, S. Tazawa, T. Yamato et al., Biology of human sodium glucose transporters. Physiological reviews SLC5A9/SGLT4, a new Na+dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life sciences, pp.733-794, 2005.

F. Jamar, J. Buscombe, A. Chiti, P. Christian, D. Delbeke et al., EANM/SNMMI guideline for 18F-FDG use in inflammation and infection Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization Journal of nuclear medicine technology, M. Suppression of 18F-FDG Myocardial Uptake Using a Fat-Allowed, Carbohydrate-Restricted Diet, pp.647-658, 2005.

Y. Kobayashi, S. Kumita, Y. Fukushima, K. Ishihara, M. Suda et al., Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet, Journal of Cardiology, vol.62, issue.5, pp.314-319, 2013.
DOI : 10.1016/j.jjcc.2013.05.004

F. Demeure, F. Hanin, A. Bol, M. Vincent, A. Pouleur et al., A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging Journal of nuclear medicine : official publication, Society of Nuclear Medicine Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis, G. 18F- FDGPET/CT: diabetes and hyperglycaemia. Nuclear medicine review Central & Eastern Europe, pp.1629-1635, 2010.

R. Boellaard, R. Delgado-bolton, W. Oyen, F. Giammarile, K. Tatsch et al., EANM procedure guidelines for tumour imaging: version 2.0. European journal of nuclear medicine and molecular imaging, pp.328-354, 2015.

F. Roy, S. Beaulieu, L. Boucher, I. Bourdeau, C. Cohade et al., Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients Journal of nuclear medicine : official publication, Society of Nuclear Medicine EANM procedure guidelines for tumour PET imaging: version 1.0. European journal of nuclear medicine and molecular imaging Effect of colony-stimulating factor and conventional-or high-dose chemotherapy on FDG uptake in bone marrow European journal of nuclear medicine and molecular imaging, pp.178-183, 2005.

D. Kim, C. Kim, S. Park, and S. Jung, Experience of Dual Time Point Brain F-18

F. Pet, /. Ct-caldarella, C. Leccisotti, L. Treglia, G. Giordano et al., Imaging in Patients with Infectious Disease. Nuclear medicine and molecular imaging Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis ? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, pp.137-142, 2010.

L. Leccisotti, F. Perna, M. Lago, M. Leo, A. Stefanelli et al., Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging, Journal of Nuclear Cardiology, vol.48, issue.8, pp.622-632, 2007.
DOI : 10.2967/jnumed.107.040253

J. Meller, C. Sahlmann, and A. Scheel, 18F-FDG PET and PET/CT in fever of unknown origin Journal of nuclear medicine : official publication, Society of Nuclear Medicine, pp.35-45, 2007.

T. Grenader, L. Shavit, M. Lustberg, O. Aras, B. Meisenberg et al., CT in patients with adult-onset Still's disease. Clinical rheumatology. 2015. 66 Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging An unusual cause of bone marrow 18- fluorodeoxyglucose uptake QJM : monthly journal of the Association of Physicians Bone-marrow uptake of (18)F-FDG during fever. The Lancet Infectious diseases A Japanese case of familial Mediterranean fever presenting diffuse bone marrow uptake of FDG-PET and high levels of neutrophil membrane CD64 expression Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response Demand-adapted regulation of early hematopoiesis in infection and inflammation Libregts SF, Nolte MA. Parallels between immune driven-hematopoiesis and T cell activation: 3 signals that relay inflammatory stress to the bone marrow. Experimental cell research Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Experimental cell research Epstein-Barr virus mimicking lymphoma on FDG-PET/CT Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT, Complete and partly unexpected diagnostic findings at 18F-FDG-PET/CT scanning in patients with suspected prosthetic valve endocarditis, pp.47-49, 2007.

V. Bronte and M. Pittet, The Spleen in Local and Systemic Regulation of Immunity, Immunity, vol.39, issue.5, pp.806-818, 2013.
DOI : 10.1016/j.immuni.2013.10.010

K. Kim, S. Kim, I. Kim, B. Kim, K. Pak et al., Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis. Nuclear medicine communications Adrenal gland volume measurement in septic shock and control patients: a pilot study, European radiology, vol.32, issue.2010, pp.1155-1161, 2010.

Q. Zhang, G. Dong, X. Zhao, M. Wang, and C. Li, Prognostic significance of hypothalamic???pituitary???adrenal axis hormones in early sepsis: a study performed in the emergency department, Intensive Care Medicine, vol.34, issue.1, pp.1499-1508, 2014.
DOI : 10.1007/s00134-007-0955-x

P. Marie, Quels sont les signes indirects de sepsis sévère en tomoscintigraphie par émission de positons au 18F-désoxy-fluoroglucose ? Médecine Nucléaire, pp.131-137, 2015.

A. Hori and H. Shibuya, Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study. Nuclear medicine and biology, pp.347-351, 2011.

J. Abele and C. Fung, Effect of Hepatic Steatosis on Liver FDG Uptake Measured in Mean Standard Uptake Values, Radiology, vol.254, issue.3, pp.917-924, 2010.
DOI : 10.1148/radiol.09090768

J. Schneller, M. Reiser, F. Beuschlein, A. Osswald, A. Pallauf et al., Linear and Volumetric Evaluation of the Adrenal Gland???MDCT-Based Measurements of the Adrenals, Academic Radiology, vol.21, issue.11, pp.1465-1474, 2014.
DOI : 10.1016/j.acra.2014.06.008

B. Bagheri, A. Maurer, L. Cone, M. Doss, and L. Adler, Characterization of the normal adrenal gland with 18F-FDG PET/CT Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol.45, issue.8, pp.1340-1343, 2004.

W. Kanczkowski, M. Sue, K. Zacharowski, M. Reincke, and S. Bornstein, The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis, Molecular and Cellular Endocrinology, vol.408, pp.241-248, 2015.
DOI : 10.1016/j.mce.2014.12.019